Dergi makalesi Açık Erişim
Timur, Selin Seda; Bhattarai, Prashant; Gursoy, Reyhan Neslihan; Vural, Imran; Khaw, Ban-An
{ "conceptrecid": "47828", "created": "2021-03-15T22:07:57.638832+00:00", "doi": "10.1007/s11095-016-2066-2", "files": [ { "bucket": "8d529f40-f696-4d5e-a504-0a1afb48fa4e", "checksum": "md5:3b4aa1f0a0a6111d8d10847b48b1fe41", "key": "bib-0e9c89da-da85-4190-b987-b2cfbdf65966.txt", "links": { "self": "https://aperta.ulakbim.gov.tr/api/files/8d529f40-f696-4d5e-a504-0a1afb48fa4e/bib-0e9c89da-da85-4190-b987-b2cfbdf65966.txt" }, "size": 235, "type": "txt" } ], "id": 47829, "links": { "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.1007/s11095-016-2066-2.svg", "bucket": "https://aperta.ulakbim.gov.tr/api/files/8d529f40-f696-4d5e-a504-0a1afb48fa4e", "doi": "https://doi.org/10.1007/s11095-016-2066-2", "html": "https://aperta.ulakbim.gov.tr/record/47829", "latest": "https://aperta.ulakbim.gov.tr/api/records/47829", "latest_html": "https://aperta.ulakbim.gov.tr/record/47829" }, "metadata": { "access_right": "open", "access_right_category": "success", "communities": [ { "id": "tubitak-destekli-proje-yayinlari" } ], "creators": [ { "affiliation": "Hacettepe Univ, Dept Pharmaceut Technol, Fac Pharm, Ankara, Turkey", "name": "Timur, Selin Seda" }, { "affiliation": "Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Bouve Coll Hlth Sci, 360 Huntington Ave, Boston, MA 02115 USA", "name": "Bhattarai, Prashant" }, { "affiliation": "Hacettepe Univ, Dept Pharmaceut Technol, Fac Pharm, Ankara, Turkey", "name": "Gursoy, Reyhan Neslihan" }, { "affiliation": "Hacettepe Univ, Dept Pharmaceut Technol, Fac Pharm, Ankara, Turkey", "name": "Vural, Imran" }, { "affiliation": "Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Bouve Coll Hlth Sci, 360 Huntington Ave, Boston, MA 02115 USA", "name": "Khaw, Ban-An" } ], "description": "Purpose LyP-1, a nine-amino-acid tumor homing peptide, selectively binds to its cognate receptor, p32. Overexpression of p32 in certain tumors should allow use of LyP-1 as a targeting agent for the delivery of therapeutic or diagnostic agents. Peptide conjugates are developed for enhanced pretargeting of MDA-MB-231 breast cancer cells with peptideantibody bispecific complexes and targeting with multipledrug/- fluorophore-conjugated nano-polymers.", "doi": "10.1007/s11095-016-2066-2", "has_grant": false, "journal": { "issue": "2", "pages": "352-364", "title": "PHARMACEUTICAL RESEARCH", "volume": "34" }, "license": { "id": "cc-by" }, "publication_date": "2017-01-01", "relations": { "version": [ { "count": 1, "index": 0, "is_last": true, "last_child": { "pid_type": "recid", "pid_value": "47829" }, "parent": { "pid_type": "recid", "pid_value": "47828" } } ] }, "resource_type": { "subtype": "article", "title": "Dergi makalesi", "type": "publication" }, "title": "Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-I in Human Breast Cancer" }, "owners": [ 1 ], "revision": 1, "stats": { "downloads": 6.0, "unique_downloads": 6.0, "unique_views": 19.0, "version_downloads": 6.0, "version_unique_downloads": 6.0, "version_unique_views": 19.0, "version_views": 21.0, "version_volume": 1410.0, "views": 21.0, "volume": 1410.0 }, "updated": "2021-03-15T22:07:57.689833+00:00" }
Görüntülenme | 21 |
İndirme | 6 |
Veri hacmi | 1.4 kB |
Tekil görüntülenme | 19 |
Tekil indirme | 6 |